News > All

France Monaco Central France Eastern France Northern France Paris (region) Southern France Western France

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1829 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Source	Date
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA.	2017-01-19
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile.	2017-01-19
Octimet Oncology N.V.. (1/19/17). "Press Release: Octimet Oncology NV Secures over EUR 11 Million to Develop Its Highly Selective MET kinase Inhibitors". Beerse.	2017-01-19
Sanofi S.A.. (1/18/17). "Press Release: Suliqua Approved in the European Union for the Treatment of Adults with Type 2 Diabetes". Paris.	2017-01-18
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA.	2017-01-18
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona.	2017-01-18
Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt.	2017-01-10
Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris.	2017-01-09
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry.	2017-01-09
ImmuNext, Inc.. (1/9/17). "Press Release: Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases". Bridgewater, NJ & Lebanon, NH.	2017-01-09
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris.	2017-01-09
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris.	2017-01-09
Noxxon Pharma N.V.. (1/6/17). "Press Release: Half-yearly Report on the Liquidity Contract with Invest Securities". Berlin.	2017-01-06
McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris.	2017-01-06
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva.	2017-01-05
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon.	2017-01-05
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA.	2017-01-05
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes.	2017-01-05
Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY.	2017-01-05
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA.	2017-01-05
Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris.	2017-01-04
Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris.	2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille.	2017-01-04
Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY.	2017-01-03
Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY.	2017-01-03
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg.	2017-01-03
Pharnext S.A.. (1/3/17). "Press Release: Pharnext Announces the Amendment to the Liquidity Contract with French Broker Gilbert Dupont and the Annual Update on Its Liquidity Agreement". Paris.	2017-01-03
Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim.	2017-01-02
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris.	2017-01-02

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)